To OTC Journal Members:

New Profile: We have decided to introduce our new profile next Friday, February 14th in honor of Valentine's Day. Be prepared to check your inbox if you want to read about revolutionary new technology which could end up widely used by automobile manufacturers.
 

The Price of Freedom

The price of freedom comes in many forms, and stock market investors are paying right now.

It doesn't matter if you agree or disagree with President's Bush's inevitable march towards war with Iraq. War is coming. George Bush is our President, and as such he is the man charged with making these tough decisions. There is no doubt he has decided to attack Iraq and put Saddam Hussein out of business.

Colin Powell's compelling presentation to the UN Security Council this past week erased any possible doubt. The only thing left to do is wait for the political process to run its course, followed by strategic bombing and CNN coverage. We believe the war will begin sometime in the next several weeks.

The pre-occupation with the pending war and geopolitical events has led to complete disinterest in the stock market. Like a wounded animal in hiding, the market is slowly bleeding to death everyday. Buyers are waiting for virtually risk free entry levels to step up to the plate, and volume is nonexistent. 

In the meantime, commodities prices are rising steadily, and the dollar continues spiraling downward. All in all, a tough environment for investors who still believe in growth companies. This is a small part of the price of freedom.

The chart of the NASDAQ since mid January tells the whole story. Price erosion everyday resulting from fear, lack of interest, rising commodity prices, and uncertainty about the war has led to a slowing declining and low volume market.

Volatility is absent from the current market, but volatility will come back, and it will be a welcome change. 

The editors of the OTC Journal continue to believe the beginning of the war will offer one of the most exciting buying opportunities of all time. Stocks will undoubtedly free fall as bids disappear and prices drop in a vacuum. Market makers will try to suck sellers in at lower prices, whipsawing investors into trading blunders.

Do not be fooled. Do not panic and give them your stock. We believe there is a high probability this war will be very swift and decisive. When Iraq attacked neighboring Kuwait a decade ago it took two weeks for the United States to turn the tide. This time we have been building our forces and preparing for this war for months. Troops, munitions, and high tech weapons are in place. Targets have already been identified. We will be ready.

We'll offer trading ideas when the time comes. Look for us to identify a couple of trading ideas in stocks that fall the farthest on the lightest volume. They will bounce the hardest. You will have to act quickly. Opportunistic money is building on the sidelines, getting ready to pounce like a mountain lion.

Since the beginning of the Bear Market in March of 2000, there have been three periods when it looked like the cycle might be complete, and we could return to a growth economy and a bull market:

• The market looked like it would improve near the end of the summer of 2001, then we had 911.
• The market looked like it would improve near the end of 2001, then we had Enronitis and the crisis of confidence.
• The market looked like it would improve at the end of 2002, and now we have war with Iraq along with spiraling oil prices and a falling dollar.

Next Week- Calypte Biomed (OTC BB: CALY) and Irvine Sensors (NASDAQ: IRSN) in the News

Calypte Biomed: Calypte Biomed is one stock which has been trading extremely well as of late. The stock doubled last week on the heels of President Bush's State of the Union address where he put the AIDS epidemic in Africa squarely back in the public spot light.

This coming Monday, February 10th, Chairman Tony Cataldo and President Nancy Katz will be presenting at the Wall Street Analyst Forum 47th Institutional Investor Conference at The Roosevelt Hotel in New York City, New York on Monday at 9:00 AM eastern time.

The presentation will be webcast live, and interested parties should register for the broadcast at the investor section of Calypte's web site, found at www.calypte.com.

In addition, Chairman Tony Cataldo has agreed to be interviewed by the OTC Journal. The date of the publication is to be scheduled soon and will be announced. Mr. Cataldo will be answering questions concerning fundamental corporate developments and the potential dilution surrounding Calypte Biomed's plan to increase the authorized number of shares from 200 million to 800 million in a special shareholders vote on the 14th. Mr. Cataldo will be addressing this issue specifically.

SwingWire.com also has a lucrative incentive model for experienced investors and traders who consistently outperform the market. Share market ideas with other like-minded investors, establish a proven track record, provide insightful commentary, attract followers and ultimately become one of the Internet's highest paid and most sought after CyberAnalysts! 

Click here to receive your FREE 30-Day Trial Membership with no further obligation. Sign Up Today! 
 

Click Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts.

All statements and expressions are the sole  opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

The editor, members of the editor's family, and/or entities with which they are affiliated, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain forward-looking statements relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.